Abbott advances coronary artery disease treatment with new intravascular lithotripsy trial
Abbott’s Coronary Intravascular Lithotripsy (IVL) System gets FDA approval for a clinical trial to enhance coronary artery disease treatment—learn more. Read More
Alcon’s Clareon Vivity IOL gains CE Mark approval, expanding vision correction options in Europe
Discover how Alcon’s Clareon Vivity IOL is transforming cataract surgery with CE Mark approval, offering presbyopia correction and extended vision clarity in Europe. Read More
Ant Group expands AI Healthcare offerings amid growing demand for digital medical solutions
Discover how Ant Group’s AI-powered healthcare solutions are transforming hospitals, doctors, and patient care with groundbreaking innovations today! Read More
VolitionRx’s Nu.Q Cancer Test targets multi-billion-dollar liquid biopsy market
VolitionRx’s Nu.Q Cancer Test is transforming liquid biopsy diagnostics, offering a non-invasive, cost-effective blood test for early cancer detection. Read More
Faster sepsis diagnosis? Accelerate Diagnostics’ WAVE System may hold the key
Accelerate Diagnostics seeks FDA clearance for its WAVE system, a rapid AST solution for serious infections. Will approval boost its struggling stock? Read More
Lupin Digital Health expands cardiac care with home-based recovery guide
Discover how Lupin Digital Health’s Post-Procedure Home-Based Care Guide is transforming cardiac recovery with expert-driven, structured home-care solutions. Read More
Unlock radiant skin naturally: The power of Vitamin E capsules for your face
Discover how Vitamin E capsules can transform your skincare routine by deeply hydrating, reducing scars, and promoting a youthful glow. Read More
Johnson & Johnson’s $55bn bet: What it means for healthcare and investors
Johnson & Johnson is investing $55 billion in U.S. manufacturing, R&D, and technology, reinforcing its leadership in pharmaceuticals. Find out more. Read More
Seegene showcases HPV genotyping solution at EUROGIN 2025 amid stock surge
Discover how Seegene’s HPV genotyping solution unveiled at EUROGIN 2025 is advancing cervical cancer screening and impacting global diagnostics. Read More
Flex expands healthcare manufacturing with new Boston-based NPI center
Discover how Flex’s Boston-based NPI center is transforming medical device manufacturing, accelerating product development, and positioning the company for future growth. Read More